Catalyst overview
Research summary
This catalyst tracks a Phase 1 data readout for KYV-101 in Multiple Sclerosis. The expected timing is based on the latest available company guidance and may change.
9/24/25- Announced updated data from Ph1 IITs at ECTRIMS '25. 03/26/26:- Updated PMS IIT data presented at ACTRIMS February 2026; additional Phase 1 data expected in 2026. 05/12/26:- Stanford PMS Ph1 IIT 12-month follow-up showed improved or stable disability and favorable biomarkers; more data H2 2026. 08/11/26:- naSPMS RMAT granted. Stanford Ph1 IIT data expected Q4 2026. PMS strategy update expected Early 2027.
Verification
Confirm timing and program details against the company announcement or filing.